Máté Kiss

Pleinlaan 2
1050 Brussels
Belgium
Pleinlaan 2
1050 Brussel
Belgium

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Máté Kiss is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

12 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots or

1 Finished

FWOSB11: FWO-SB-Beurs: Blocking protumoral functions of tumor-associated macrophages to improve chemotherapy in cancer
Van Ginderachter, J. & Kiss, M.
1/01/16 → 31/12/19
Project: Applied

222 Citations
6 h-Index
6 Article
4 Scientific review
1 Poster

IL1β Promotes Immune Suppression in the Tumor Microenvironment Independent of the Inflammasome and Gasdermin D
Kiss, M., Vande Walle, L., Saavedra, P. H. V., Lebegge, E., Van Damme, H., Murgaski, A., Qian, J., Ehling, M., Pretto, S., Bolli, E., Keirsse, J., Bardet, P. M. R., Arnouk, S. M., Elkrim, Y., Schmoetten, M., Brughmans, J., Debraekeleer, A., Fossoul, A., Boon, L., Raes, G. & 8 others, van Loo, G., Lambrechts, D., Mazzone, M., Beschin, A., Wullaert, A., Lamkanfi, M., Van Ginderachter, J. A. & Laoui, D., Mar 2021, In : Cancer Immunology Research. 9, 3, p. 309-323 15 p.
Research output: Contribution to journal › Article
1 Citation (Scopus)
Therapeutic depletion of CCR8+ tumor-infiltrating regulatory T cells elicits antitumor immunity and synergizes with anti-PD-1 therapy
Van Damme, H., Dombrecht, B., Kiss, M., Roose, H., Allen, E., Van Overmeire, E., Kancheva, D., Martens, L., Murgaski, A., Bardet, P., Blancke, G., Jans, M., Bolli, E., Martins, M. S., Elkrim, Y., Dooley, J., Boon, L., Schwarze, J. K., Tacke, F., Movahedi, K. & 9 others, Vandamme, N., Neyns, B., Ocak, S., Scheyltjens, I., Vereecke, L., Nana, F. A., Merchiers, P., Laoui, D. & Van Ginderachter, J. A., Feb 2021, In : Journal for immunotherapy of cancer. 9, 2, 16 p., e001749.
Research output: Contribution to journal › Article
Innate Immune Defense Mechanisms by Myeloid Cells That Hamper Cancer Immunotherapy: Innate Immune Defense Mechanisms by Myeloid Cells That Hamper Cancer Immunotherapy
Lebegge, E., Arnouk, S. M., Bardet, P. M. R., Kiss, M., Raes, G. & Van Ginderachter, J. A., 9 Jul 2020, In : Frontiers in Immunology. 11, 1395, p. 1-14 14 p., 1395.
Research output: Contribution to journal › Scientific review
2 Citations (Scopus)
Systemic Reprogramming of Monocytes in Cancer
Kiss, M., Caro, A. A., Raes, G. & Laoui, D., 17 Sep 2020, In : Frontiers in Oncology. 10, 12 p., 1399.
Research output: Contribution to journal › Article
2 Citations (Scopus)
High Salt Inhibits Tumor Growth by Enhancing Anti-tumor Immunity
Willebrand, R., Hamad, I., Van Zeebroeck, L., Kiss, M., Bruderek, K., Geuzens, A., Swinnen, D., Fernandes Côrte-Real, B., Markó, L., Lebegge, E., Laoui, D., Kemna, J., Kammertoens, T., Brandau, S., Van Ginderachter, J. & Kleinewietfeld, M., 4 Jun 2019, In : Frontiers in Immunology. 10, JUN, 1141.
Research output: Contribution to journal › Article

Open Access
6 Citations (Scopus)

Best Poster in Human Health
Máté Kiss (Recipient), 8 Feb 2018
Prize: Prize (including medals and awards)

File
Germaine Eisendrath-Dubois Foundation Award in Cancer Research
Máté Kiss (Recipient), 2019
Prize: Prize (including medals and awards)
Poster Prize
Máté Kiss (Recipient), 19 Oct 2018
Prize: Prize (including medals and awards)

11 Talk or presentation at a conference

Inflammasome-independent IL-1β release by myeloid cells in the tumor microenvironment promotes immune suppression and therapy resistance
Máté Kiss (Speaker)
14 Sep 2019
Activity: Talk or presentation › Talk or presentation at a conference
Analysis of the transcriptome of circulating Ly6C(hi) monocytes reveals JAM-A as a novel marker of tumor-induced monocyte reprogramming
Máté Kiss (Presenter)
13 Sep 2019
Activity: Talk or presentation › Talk or presentation at a conference
Non-canonical IL-1β release by myeloid cells promotes tumor progression and resistance to immunotherapy
Máté Kiss (Presenter)
18 Feb 2018
Activity: Talk or presentation › Talk or presentation at a conference
Inflammasome-independent IL-1β release by myeloid cells promotes vessel destabilization and immune suppression in the tumor microenvironment
Máté Kiss (Presenter)
19 Oct 2018
Activity: Talk or presentation › Talk or presentation at a conference
Inflammasome-independent IL-1β release by tumor-infiltrating myeloid cells promotes vessel destabilization and T-cell exclusion
Máté Kiss (Speaker)
14 Jun 2018
Activity: Talk or presentation › Talk or presentation at a conference